N-acetyl-β-D-glucosaminidase assay reagent (MPT substrate method) - NMPA Registration 冀械注准20142400359
Access comprehensive regulatory information for N-acetyl-β-D-glucosaminidase assay reagent (MPT substrate method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 冀械注准20142400359 and owned by Langfang Hengyi Biotechnology Co., Ltd.. The device was approved on November 07, 2019.
This page provides complete registration details including registrant information, province location (Hebei), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
For in vitro quantitative determination of N-acetyl-β-D-glucosasidase (NAG) viability in human serum or urine.
用于体外定量测定人血清或尿液中N-乙酰-β-D-氨基葡萄糖苷酶（NAG）的活力。
Reagent 1: Citric acid buffer, 200 mmol/L. Reagent 2: 6-Methyl-2-mercaptopyridine-N-acetyl-β-D-glucosanoside (MPT-NAG), 19.3 mmol/L.
试剂1：柠檬酸缓冲液，200mmol/L。试剂2：6-甲基-2-巯基吡啶-N-乙酰-β-D-氨基葡萄糖苷（MPT-NAG），19.3mmol/L。